Cambrex Corporation (CBM) has risen sharply, recording gains of 2.75% in the past 4 weeks. However, the stock has corrected -4.59% in the past 1 week, providing a good buying opportunity on dips. On a relative basis, the stock has outperformed the S&P 500 by 3.31% in the past 4 weeks, but has underperformed the S&P 500 in the past 1 week.
The stock has recorded a 20-day Moving Average of 1.92% and the 50-Day Moving Average is 5.21%.The 200 Day SMA reached 2.5%
Cambrex Corporation (NYSE:CBM): After opening at $44.09, the stock dipped to an intraday low of $43.62 on Friday. However, the bulls stepped in to buy at lower levels and pushed the stock higher. The stock touched an intraday high of $44.67 and the buying power remained strong till the end. The stock closed at $44.46 for the day, a gain of 0.88% for the day session. The total traded volume was 582,725. The stocks close on the previous trading day was $44.46.
Cambrex Corporation (Cambrex) is a life sciences company that provides products and services for the development and commercialization of new and generic therapeutics. The Company supplies its products and services worldwide to innovator and generic pharmaceutical companies. The Companys customers include generic drug companies and companies that discover and commercialize small molecule human therapeutics using organic chemistry. Its business consists of the custom development and manufacture of pharmaceutical ingredients derived from organic chemistry. The Companys products include active pharmaceutical ingredients (APIs), pharmaceutical intermediates and, to a lesser extent, other fine chemicals. Cambrex has three operating segments, which are manufacturing facilities that have been aggregated as one reportable segment.